HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Svetlana Bolshakov Selected Research

Amyloid Precursor Protein Secretases (beta-Secretase)

11/2015Targeting the Notch pathway: A potential therapeutic approach for desmoid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Svetlana Bolshakov Research Topics

Disease

14Neoplasms (Cancer)
01/2022 - 08/2002
6Liposarcoma
01/2022 - 03/2011
5Neurofibrosarcoma (MPNST)
01/2022 - 01/2011
5Sarcoma (Soft Tissue Sarcoma)
03/2016 - 09/2008
4Neoplasm Metastasis (Metastasis)
01/2016 - 09/2008
3Aggressive Fibromatosis (Desmoid)
12/2011 - 11/2008
2Carcinogenesis
01/2022 - 02/2013
2Genomic Instability
03/2016 - 01/2016
1Breast Neoplasms (Breast Cancer)
01/2016
1Myxoid Liposarcoma
01/2016
1Cicatrix (Scar)
11/2015
1Carcinoma (Carcinomatosis)
11/2015
1B-Cell Leukemia (Leukemia, B Cell)
12/2011
1Fibrosarcoma
09/2008
1Leiomyosarcoma
09/2008
1Skin Neoplasms (Skin Cancer)
08/2002
1Psoriasis (Pustulosis Palmaris et Plantaris)
08/2002
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2002

Drug/Important Bio-Agent (IBA)

4CateninsIBA
11/2015 - 08/2011
3Small Interfering RNA (siRNA)IBA
11/2015 - 06/2011
2SAR405838IBA
01/2022 - 03/2016
2Histone Deacetylase InhibitorsIBA
01/2016 - 01/2011
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2015 - 03/2011
2LigandsIBA
02/2013 - 06/2011
2Cyclin D1IBA
02/2013 - 04/2012
2Biomarkers (Surrogate Marker)IBA
12/2011 - 12/2011
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
12/2011 - 06/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2011 - 06/2011
2Tyrosine Kinase InhibitorsIBA
06/2011 - 09/2008
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2011 - 09/2008
1Phosphotransferases (Kinase)IBA
10/2017
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2016
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1Transcription Factors (Transcription Factor)IBA
01/2016
1olaparibIBA
01/2016
1nirogacestatIBA
11/2015
1Basic Helix-Loop-Helix Transcription FactorsIBA
11/2015
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
11/2015
1Proto-Oncogene Proteins c-metIBA
08/2015
1Chemokine ReceptorsIBA
02/2013
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
02/2013
1Caseins (Casein)FDA Link
04/2012
1Casein Kinases (Casein Kinase)IBA
04/2012
1MicroRNAs (MicroRNA)IBA
04/2012
1MidkineIBA
12/2011
1PPAR gammaIBA
12/2011
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
12/2011
1SurvivinIBA
12/2011
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
06/2011
1AntigensIBA
01/2011
1IntegrasesIBA
01/2011
1withaferin AIBA
04/2010
1Pharmaceutical PreparationsIBA
04/2010
1VimentinIBA
04/2010
1beta CateninIBA
11/2008
1vandetanib (ZD6474)IBA
09/2008
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2008
1ErbB Receptors (EGF Receptor)IBA
09/2008
1LuciferasesIBA
09/2008
1Furocoumarins (Furanocoumarins)IBA
08/2002
1Ficusin (Psoralen)IBA
08/2002

Therapy/Procedure

5Therapeutics
01/2022 - 09/2008
1Subcutaneous Injections
01/2022
1Radiotherapy
08/2015
1Drug Therapy (Chemotherapy)
09/2008